Israel Englander Angion Biomedica Corp. Transaction History

Millennium Management LLC

  • $207 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$0.48 - $1.02 $2,868 - $6,096
-5,977 Reduced 7.93%
69,365 $40,000
Q4 2022

Feb 14, 2023
SELL
$0.8 - $1.0 $40,208 - $50,261
-50,261 Reduced 40.02%
75,342 $61,000
Q3 2022

Nov 14, 2022
SELL
$0.94 - $1.23 $54,336 - $71,100
-57,805 Reduced 31.52%
125,603 $116,000

About Angion Biomedica Corp.

ANGN Quotes by TradingView
  • Ticker ANGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,113,300
  • Description
  • Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...
More about ANGN
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email